AstraZeneca to buy pharmaceutical firm Alexion for $39 billion
NEW DELHI: Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said that it is buying US biotech firm Alexion for $39 billion to boost its work on immunology. The boards of directors of both companies have unanimously approved the acquisition. Subject to receipt of regulatory clearances […]